November 03, 2006

Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2006

October 30, 2006

Momenta Pharmaceuticals to Present at the Cowen and Company 7th Annual Global Health Care Conference

October 30, 2006

Momenta Pharmaceuticals to Present at the Rodman & Renshaw 8th Annual Healthcare Conference

October 30, 2006

Momenta Pharmaceuticals to Present at the CIBC World Markets 17th Annual Health Care Conference

October 27, 2006

Momenta Pharmaceuticals to Present at the MBC Mass Opportunities Biotechnology Investment Conference

October 12, 2006

Momenta Pharmaceuticals to Present at BIO Investor Forum 2006

October 11, 2006

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2006 Financial Results

October 10, 2006

Momenta Pharmaceuticals Commences Phase I Clinical Study for M118

September 15, 2006

Momenta Pharmaceuticals to Present at the Bank of America 36th Annual Investment Conference

September 07, 2006

Momenta Pharmaceuticals to Present at the Think Equity Partners 4th Annual Growth Conference

September 06, 2006

Momenta Pharmaceuticals to Present at the Bear Stearns 19th Annual Healthcare Conference

August 31, 2006

Momenta Pharmaceuticals to Present at NewsMakers in the Biotech Industry Conference

August 31, 2006

Momenta Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2006

August 22, 2006

Momenta Pharmaceuticals Announces Appointment of Craig A. Wheeler as Chief Executive Officer

August 8, 2006

Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2006

July 31, 2006

Momenta Pharmaceuticals Files Investigational New Drug Application for Novel Anticoagulant for Acute Coronary Syndromes

July 28, 2006

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2006 Financial Results

July 25, 2006

Momenta Pharmaceuticals and Sandoz Sign Exclusive Collaboration to Develop Complex Generics and Follow-On Versions of Biotechnology Drugs

June 6, 2006

Momenta Pharmaceuticals Announces Date for 2006 Annual Meeting of Stockholders

May 9, 2006

Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2006

April 7, 2006

Momenta Pharmaceuticals Announces Appointment of of Paul D. Goldenheim, M.D. to Board of Directors

February 14, 2006

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter of 2005

February 8, 2006

Momenta Pharmaceuticals to Present at the Deutsche Bank Small Cap Growth Conference

February 7, 2006

Momenta Pharmaceuticals to Present at BIO CEO & Investor Conference 2006

January 31, 2006

Momenta Pharmaceuticals to Present at NASDAQ Growth Conference

January 18, 2006

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter 2005 Financial Results

November 14, 2005

Momenta Pharmaceuticals Selected to join NASDAQ Biotechnology Index

November 2, 2005

Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2005

October 26, 2005

Momenta Pharmaceuticals to Present at the MBC Mass Opportunities Biotechnology Investment Conference.

October 18, 2005

Momenta Pharmaceuticals to Present at the C.E.Unterberg, Towbin Emerging Growth Life Sciences Conference

October 14, 2005

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2005 Financial Results

October 14, 2005

Momenta Pharmaceuticals to Present at Bio Investor Forum 2005

September 22, 2005

Momenta Pharmaceuticals to Present at UBS Global Life Sciences Conference

August 30, 2005

Momenta Pharmaceuticals Announces Abbreviated New Drug Application Filing for M-Enoxaparin

August 10, 2005

Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2005

July 25, 2005

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2005 Financial Results

July 21, 2005

Momenta Pharmaceuticals Announces Pricing of Public Offering of 4,827,300 Shares of Common Stock

July 18, 2005

Momenta Pharmaceuticals Announces Public Offering of 4 Million Shares of Common Stock

June 24, 2005

Momenta Pharmaceuticals to Present at the Bear Stearns Boston Biotech conference

June 13, 2005

Momenta Pharmaceuticals Announces the Appointment of Peter Barrett as Chairman of Board of Directors

June 6, 2005

Momenta Pharmaceuticals to Present at The 2005 Pacific Growth Equities Life Sciences Growth Conference

May 23, 2005

Momenta Pharmaceuticals Names Vice President, Strategic Product Development

May 10, 2005

Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2005

April 28, 2005

Momenta Pharmaceuticals to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged Conference

April 27, 2005

Momenta Pharmaceuticals to Present at the Second Annual Rodman & Renshaw Techvest Global Healthcare Conference

April 25, 2005

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2005 Financial Results


Momenta Pharmaceuticals Announces Date for 2005 Annual Meeting of Stockholders


Momenta Pharmaceuticals to present at the Deutchse Bank Securities 30th Annual Health Care Conference

April 12, 2005

Momenta Pharmaceuticals Announces Executive Promotions

March 29, 2005

Momenta Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference

March 17, 2005

Momenta Pharmaceuticals Announces Changes to Board of Directors

March 10, 2005

Momenta Pharmaceuticals to Present at SG Cowen's 25th Annual Health Care Conference

February 10, 2005

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 2004

February 3, 2005

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter 2004 Financial Results

January 13, 2005

Momenta Pharmaceuticals Announces Goals for Glycoprotein Program

January 6, 2005

Momenta Pharmaceuticals to Present at JP Morgan's 23rd Annual Healthcare Conference

November 16, 2004

Momenta Pharmaceuticals Announces Appointments in Manufacturing Management and Investor Relations

November 5, 2004

Momenta Pharmaceuticals Reports Financial Results for Third Quarter 2004

October 29, 2004

Momenta Pharmaceuticals to Present at CIBC World Markets Fifteenth Annual Healthcare Conference

October 28, 2004

Momenta Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2004 Financial Results

October 12, 2004

Momenta Pharmaceuticals'Technology Featured in Nature Reviews

September 16, 2004

Momenta Pharmaceuticals To Be Included in Russell 3000® Index

September 14, 2004

Momenta Pharmaceuticals to Present ThinkEquity Partners Growth Conference

September 2, 2004

Momenta Pharmaceuticals to Webcast Presentation at Bear Stearns 17th Annual Healthcare Conference

August 16, 2004

Momenta Pharmaceuticals Reports Financial Results for Second Quarter 2004

July 23, 2004

Momenta Pharmaceuticals to Webcast Presentation at Banc of America Securities "New Products, New Paradigms in Health Care" Conference

June 28, 2004

Momenta Pharmaceuticals Inc. Announces Exercise of Over-Allotment Option

June 21, 2004

Momenta Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

This part of our website contains archival information, which should not be considered current and may no longer be accurate.

March 11, 2004

Momenta Pharmaceuticals Inc.Files for Initial Public Offering

March 1, 2004

Momenta Raises $20.5 Million in Series C Equity Financing

January 9, 2004

Momenta Pharmaceuticals to Present at the 22nd Annual JP Morgan Healthcare Conference

November 18, 2003

Momenta Pharmaceuticals and Sandoz, Inc. Form Strategic Alliance for the Application of Breakthrough Sugar Technology to Product Development

May 21, 2003

Momenta Pharmaceuticals Secures $19 Million in Series B Equity Financing